Lutein by Scleral Iontophoresis in AMD

The objective of the clinical investigation is to evaluate the performance, safety and degree of tolerability resulting from the use of the iontophoresis medical device in adult subjects diagnosed with AMD stage 3 (AREDS classification) in one or both eyes.

NCT Number	NCT06925893
Lead Sponsor	Federico II University
Conditions	Stage 3 AMD
Enrollment	80 participants
Start Date	2024-11-01
Primary Completion	2024-12-01 (estimated)
Study Completion	2025-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-13